Antibody-Like Domains: Pioneering Novel Conjugates for Inflammation Therapy
Time: 11:00 am
day: Conference Day 1
Details:
- Explore the unique properties of soloMERs and their potential as versatile targeting moieties for novel conjugate designs in inflammation therapy
- Discuss the evolution of soloMERs from traditional ADCs in oncology to novel applications in inflammation therapy, highlighting the adaptability and versatility of the platform in addressing diverse disease indications
- Delve into the frontier of novel anti-inflammatory payloads, showcasing the potential for targeted delivery of novel therapeutics in inflammation-related disorders
